Health Alert: Sales of Essure birth-control implant to be halted by Bayer; U.S. was last nation to sell controversial device

The pharmaceutical giant's announcement ends a protracted battle over an implant that thousands of women blame for serious problems including persistent pain and perforations of the uterus and fallopian tubes. The United States is the last country in which Essure is being sold. Last September, citing "commercial reasons," Bayer announced it was ending sales outside the United States.

Democracy Dies in Darkness     Health Alert Jul 20, 12:00 PM     Sales of Essure birth-control implant to be halted by Bayer; U.S. was last nation to sell controversial device The pharmaceutical giant's announcement ends a protracted battle over an implant that thousands of women blame for serious problems including persistent pain and perforations of the uterus and fallopian tubes. The United States is the last country in which Essure is being sold. Last September, citing "commercial reasons," Bayer announced it was ending sales outside the United States. Read more » Advertisement You received this email because you signed up for news alerts from The Washington Post. Manage my newsletters and alerts | Unsubscribe Privacy Policy | Help ©2018 The Washington Post, 1301 K St NW, Washington DC 20071